Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)
Impact of COVID-19 Pandemic in Perinatal Mental Health
Sponsor: Bar-Ilan University, Israel
Listed as NCT04595123, this observational or N/A phase trial focuses on Anxiety and Depression and remains completed. Sponsored by Bar-Ilan University, Israel, it has been updated 7 times since 2020, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2021 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Mar 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Mar 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Jun 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bar-Ilan University, Israel
- Beder College University. Albania
- European University Cyprus
- Groupe Hospitalier du Havre
- Instituto de Investigação Biomédica de Malaga. Spain
- Instituto de Saude Publica da Universidade do Porto
- King's College London
- Kırklareli University
- Mackenzie Presbiterian University, São Paulo, Brazil
- Medical University of Sofia
- Mount Carmel Health System
- Universidad Loyola Andalucia
- Universidad Nacional de Educación a Distancia
- Universidad de Concepcion
- Universidade Católica Portuguesa
- University of Athens
- University of Coimbra
- University of Huelva
- University of Malta
- University of Minho
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Athens, Greece , Braga, Portugal , Concepción, Chile , Kırklareli, Turkey (Türkiye) , Le Havre, France , London, United Kingdom , Msida, Malta , Nicosia, Cyprus , Ramat Gan, Israel , Seville, Spain and 3 more locations